留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

应中央军委要求,2022年9月起,《药学实践杂志》将更名为《药学实践与服务》,双月刊,正文96页;2023年1月起,拟出版月刊,正文64页,数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿!

抑郁症治疗依从性研究概述

韦龙静

韦龙静. 抑郁症治疗依从性研究概述[J]. 药学实践与服务, 2012, 30(6): 415-417,474. doi: 10.3969/j.issn.1006-0111.2012.06.005
引用本文: 韦龙静. 抑郁症治疗依从性研究概述[J]. 药学实践与服务, 2012, 30(6): 415-417,474. doi: 10.3969/j.issn.1006-0111.2012.06.005
WEI Long-jing. Studies on compliance in the treatment of depression[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(6): 415-417,474. doi: 10.3969/j.issn.1006-0111.2012.06.005
Citation: WEI Long-jing. Studies on compliance in the treatment of depression[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(6): 415-417,474. doi: 10.3969/j.issn.1006-0111.2012.06.005

抑郁症治疗依从性研究概述

doi: 10.3969/j.issn.1006-0111.2012.06.005

Studies on compliance in the treatment of depression

  • 摘要: 笔者通过查阅国内外文献,对抑郁症治疗依从性的定义、测量方法、等级划分、研究现状、影响因素、干预措施等内容进行综述。阐明抑郁症治疗依从性受多方面因素共同影响,对患者制定针对性的依从性干预计划是一种有效提高抑郁症治疗依从性的方法,同时可提高抑郁症的治疗缓解率。该综述旨在提高国内同行对抑郁症治疗依从性的关注,并为相关研究提供参考和依据。
  • [1] NIMH/NIH Consensus Development Panel.Mood disorders:pharmacological prevention of recurrences[J].Am J Psychiatry,1985,142:469.
    [2] Frank E,Kupfer DJ,Perel JM,et al.Three-year outcomes for maintenance therapies in recurrent depression[J].Arch Gen Psychiatry,1990,47(12):1093.
    [3] Kupfer DJ,Frank E,Perel JM,et al.Five-year outcome for maintenance therapies in recurrent depression[J].Arch Gen Psychiatry,1992,49(10):769.
    [4] Greden JF.Antidepressant maintenance medications:when to discontinue and how to stop[J].J Clin Psychiatry,1993,54(Suppl 8):39.
    [5] Haynes RB,Taylor DW,Sackett DL. Compliance in Health Care[M].Baltimore:The Johns Hopkins University Press,1979:1
    [6] Frank E,Perel JM,Mallinger AG,et al.Relationship of pharmacologic compliance to long-term prophylaxis in recurrent depression[J].Psychopharmacol Bulletin,1992,28(3):231.
    [7] Demyttenaere K.Compliance during treatment with antidepressants[J].J Affect Disorders,1997,43(1):27.
    [8] Tollefson GD. Adverse drug reactions/interactions in maintenance therapy[J]. J Clin Psychiatry,1993,54(Suppl 8):48.
    [9] Altamura AC,Mauri M.Plasma concentrations,information and therapy adherence during long-term treat-ment with antidepressants[J].Br J Clin Pharmacol,1985,20(6):714.
    [10] Kruse W,Weber E.Dynamics of drug regimen compliance-its assessment by microprocessor-based monitoring[J].Eur J Pharmacol,1990,38(6):561.
    [11] George CF,Peveler RC,Heiliger S,et al.Compliance with tricyclic antidepressants:the value of four different methods of assesment[J].Br J Clin Pharmacol,2000,50(2):166.
    [12] Demyttenaere K,Adelin A,Patrick M,et al.Six-month compliance with antidepressant medication in the treatment of major depressive disorder[J].Int Clin Psychopharmacol,2008,23(1):36.
    [13] Demyttenaere K.Risk factors and predictors of compliance in depression[J]. Eur Neuropsychopharmacol,2003,13 (Suppl 3):S69.
    [14] DiMatteo MR,Lepper HS,CroghanTW.Depression is a risk factor for non-compliance with medical treatment:meta-analysis of the effects of anxiety and depression on patient adherence[J].Arch Intern Med,2000,160(14):2101.
    [15] Sirey JA,Bruce ML,Alexopoulos GS,et al.Stigma as a barrier to recovery:Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence[J].Psychiatric Services,2001,52(12):1615.
    [16] Åkerblad AC,Bengtsson F,Holgersson M,et al.Identification of primary care patients at risk of nonadherence to antidepressant treatment[J].Patient Prefer Adherence,2008,2:379.
    [17] Compton MT,Rudisch BE,Weiss PS,et al.Predictors of psychiatristreported treatment-compliance problems among patients in routine US psychiatric care[J].Psychiatry Res,2005,137(1):29.
    [18] Kamali M,Kelly BD,Clarke M,et al.A prospective evaluation of adherence to medication in first episode schizophrenia[J].Eur Psychiatry,2006,21(1):29.
    [19] Demyttenaere K,Van Ganse E,Gregoire J,et al.Compliance in depressed patients treated with fluoxetine or amitriptyline[J].Int Clin Psychopharmacol,1998,13(1):11.
    [20] DiMatteo MR,Sherbourne CD,Hays RD,et al.Physicians' characteristics influence patients'adherence to medical treatment:results from the medical outcomes study[J].Health Psychol,1993,12(2):93.
    [21] Delgado PL.Approaches to the enhancement of patient adherence to antidepressant medication treatment[J].J Clin Psychiatry,2000,61(suppl 2):6.
    [22] Peveler R,George C,Kinmouth AL,et al. Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care:randomized controlled trial[J]. BMJ,1999,319(7210):612.
    [23] Åkerblad AC,Bengtsson F,Ekselius L,et al.Effects of an educational compliance enhancement programme and therapeutic drug monitoring on treatment adherence in depressed patients managed by general practitioners[J].Int Clin Psychopharmacol,2003,18(6):347.
    [24] Sirey JA,Bruce ML,Kales HC.Improving Antidepressant Adherence and Depression Outcomes in Primary Care:The Treatment Initiation and Participation (TIP) Program[J].Am J Geriatr Psychiatry,2010,18(6):554.
    [25] 张慧敏,黄贞杰,许晶,等.健康教育干预对综合医院抑郁症治疗依从性的影响[J].临床心理卫生,2007,21(9):630.
    [26] 张慧敏,许晶,李明,等.抑郁症治疗依从性的相关因素分析[J].中国临床康复,2006,10(46):16.
  • [1] 宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅.  帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(7): 1-7. doi: 10.12206/j.issn.2097-2024.202303023
    [2] 丁华敏, 郭羽晨, 秦春霞, 宋志兵, 孙莉莉.  消风止痒颗粒通过降低白三烯水平对小鼠特应性皮炎急性瘙痒的治疗作用研究 . 药学实践与服务, 2024, 42(5): 211-216. doi: 10.12206/j.issn.2097-2024.202306031
    [3] 景凯, 杨慈荣, 张圳, 臧艺蓓, 刘霞.  黄芪甲苷衍生物治疗慢性心力衰竭小鼠的药效评价及作用机制研究 . 药学实践与服务, 2024, 42(5): 190-197. doi: 10.12206/j.issn.2097-2024.202310004
    [4] 王耀振, 徐灿, 吕顺莉, 田泾, 张东炜.  钾离子竞争性酸阻滞剂的药学特征研究进展 . 药学实践与服务, 2024, 42(7): 1-7. doi: 10.12206/j.issn.2097-2024.202306040
    [5] 马兹芬, 许维恒, 金煜翔, 薛磊.  食管癌的靶向治疗与免疫治疗研究进展 . 药学实践与服务, 2024, 42(6): 231-237. doi: 10.12206/j.issn.2097-2024.202306008
    [6] 唐淑慧, 凤美娟, 薛智霞, 鲁桂华.  帕博利珠单抗治疗所致免疫相关不良反应与中医体质的相关性研究 . 药学实践与服务, 2024, 42(5): 217-222. doi: 10.12206/j.issn.2097-2024.202311029
    [7] 刘丽艳, 余小翠, 孙传铎.  纳武利尤单抗治疗非小细胞肺癌有效性及安全性的Meta分析 . 药学实践与服务, 2024, 42(): 1-6. doi: 10.12206/j.issn.2097-2024.202310044
    [8] 张晶晶, 索丽娜, 郑兆红.  89例细菌性肝脓肿的临床特征及抗感染治疗分析 . 药学实践与服务, 2024, 42(6): 267-272. doi: 10.12206/j.issn.2097-2024.202302039
  • 加载中
计量
  • 文章访问数:  5133
  • HTML全文浏览量:  216
  • PDF下载量:  1908
  • 被引次数: 0
出版历程
  • 收稿日期:  2012-02-02
  • 修回日期:  2012-04-25

抑郁症治疗依从性研究概述

doi: 10.3969/j.issn.1006-0111.2012.06.005

摘要: 笔者通过查阅国内外文献,对抑郁症治疗依从性的定义、测量方法、等级划分、研究现状、影响因素、干预措施等内容进行综述。阐明抑郁症治疗依从性受多方面因素共同影响,对患者制定针对性的依从性干预计划是一种有效提高抑郁症治疗依从性的方法,同时可提高抑郁症的治疗缓解率。该综述旨在提高国内同行对抑郁症治疗依从性的关注,并为相关研究提供参考和依据。

English Abstract

韦龙静. 抑郁症治疗依从性研究概述[J]. 药学实践与服务, 2012, 30(6): 415-417,474. doi: 10.3969/j.issn.1006-0111.2012.06.005
引用本文: 韦龙静. 抑郁症治疗依从性研究概述[J]. 药学实践与服务, 2012, 30(6): 415-417,474. doi: 10.3969/j.issn.1006-0111.2012.06.005
WEI Long-jing. Studies on compliance in the treatment of depression[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(6): 415-417,474. doi: 10.3969/j.issn.1006-0111.2012.06.005
Citation: WEI Long-jing. Studies on compliance in the treatment of depression[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(6): 415-417,474. doi: 10.3969/j.issn.1006-0111.2012.06.005
参考文献 (26)

目录

    /

    返回文章
    返回